The staff at Rhode Island Mood & Memory has been actively involved in clinical research trials for the treatment and prevention of Alzheimer's disease for over twenty years. We have participated in the pivotal trials that have brought all the currently FDA approved medications to market. Today we are actively involved in cutting edge research for the prevention of Alzheimer's disease using active anti-amyloid therapies. We also have ongoing trials that look at the effect of passive vaccination using anti-amyloid immunotherapy to hopefully slow or arrest the progression of the disease in patients with mild to moderate Alzheimer's disease.
